Latest news
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - FinvizFinviz · Mon, 10 Aug 2026 11:57:39 GMTAccendra Health Reports Second Quarter 2026 Financial Results - FinvizFinviz · Mon, 10 Aug 2026 11:49:07 GMTN-able Announces Second Quarter 2026 Results - FinvizFinviz · Mon, 10 Aug 2026 11:49:07 GMT